www.standoutstocks.com: Stocks That Stand Out For Nov. 4th, 2009 Are LLFH, XMDC, NVSR, ETLY, ACTC

Stocks That Standout For Nov. 4th, 2009 are L&L International Holdings, Inc. (OTC Bulletin Board: LLFH), XTend Medical Corporation (PINKSHEETS: XMDC), NavStar Technologies, Inc. (PINKSHEETS: NVSR), ECOtality, Inc. (OTCBB: ETLY), Advanced Cell Technology, Inc. (OTCBB: ACTC)

Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com _________________________________________________

L&L International Holdings Names Dennis Bracy, Leading Energy Strategist, to the Board

SEATTLE, Nov 04, 2009 -- L&L International Holdings, Inc. (OTC Bulletin Board: LLFH), a U.S.-based company operating coal businesses in China, today announced that Dennis Bracy is appointed to the Company's Board as an Independent Director effective November 2, 2009.

Bracy has a lifetime commitment to energy and to strengthening U.S.-China relations. He is the CEO of the U.S.-China Clean Energy Forum. Bracy's previous professional positions include: President of Hill & Knowlton Technology, Director of Corporate Relations at ITT Corporation, and Vice President of Kaiser Aluminum.

Dickson Lee, Chairman of L&L stated: "We are thrilled that Dennis Bracy joins our Board of Directors. His appointment demonstrates our commitment to finding profitable yet responsible solutions to China's energy needs." The Company also announced the appointment of John Levy to its Advisory Panel. Levy is a recognized leader in corporate governance and compliance, and he has served as CFO of public and private companies for more than 10 years.

About L&L Founded in 1995, L&L focus on the vast coal (energy) market in China and operates profitable coal mines and coal consolidation facilities in the resource-rich Yunnan Province. See Company's website at www.lnlinternational.com.

Regarding Forward-Looking Information This press release may contain forward-looking information intended to be covered by the Safe Harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

XTend Medical Corporation (XMDC) Retains Carl Duncan, Esq., to Handle Company's Legal Strategy and Affairs

SUN VALLEY, CA, Nov 03, 2009 -- XTend Medical Corporation (PINKSHEETS: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, announced today the company has retained Mr. Carl Duncan, Esq., to become corporate counsel and to handle the filings necessary for the company to migrate to the OTC Bulletin Board trading market.

"We're extremely pleased that Mr. Duncan has agreed to serve as our independent corporate counsel and securities attorney to handle all of our legal strategies and affairs. He will also be handling all the filings necessary for XTend Medical to apply for a listing on the OTC Bulletin Board trading markets upon completion of our company's audited financials. Mr. Duncan has over 37 years' experience in corporate securities law and has represented more than 350 issuers in as many as 48 states concurrently and in an aggregate of 15 countries. Our continued work with Mr. Duncan will spearhead our proposed upcoming listing to the Bulletin Board will be done in accordance with all securities laws and his knowledge in international securities will also serve XTend well as we seek listings, in due course, on other capital markets globally," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

About XTend Medical Corporation XTend Medical Corporation is a company that specializes in the manufacturing and distribution of the latest in telemedicine and telehealth solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their continued efforts in identifying global companies with true product potential in the healthcare industry puts them in an advantageous position to capitalize on a global basis. For further information, please contact them at info@bioharpunius.com The new website can be located at www.bioharpunius.com Forward-Looking Statements This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

NavStar Technologies, Inc. Issues a Shareholder Update

NavStar Technologies, Inc. Provides an Update on the Company's Focus for November and December 2009

ANAHEIM, CA, Nov 04, 2009 -- NavStar Technologies, Inc. (PINKSHEETS: NVSR), a firm focused on developing and commercializing multi-national asset tracking and monitoring devices for vehicles and high value cargo, today issued a shareholder update on several key initiative for the last 60 days of 2009.

Dear Shareholders, As you know, significant progress has been made this year to identify partners in several countries and to get distribution agreements signed. This effort, while time consuming and difficult, will result in purchase orders for NavStar products in late 2009 and first quarter of 2010. Below is an update on a few of the "near term" opportunities that will unfold in the next 60 to 90 days.

* The contract with the transportation department in Ecuador is in the final stages of the field trial and units will ship in early 2010. We are the vendor of choice and delays are due to personnel changes within the government of Ecuador.

* Final terms for a Joint Venture in Korea have been finalized and will be signed this month.

* A field trial with a US trucking company will begin in late November or early December.

* The opportunity that was announced in early October for distribution into the Middle East is still alive but taking much longer than expected to reach agreeable terms and conditions.

The effort to get a distribution agreement signed, conduct a field trial and get a purchase order takes time and has of course been more difficult given the current economic climate. In spite of these conditions we have established a diverse customer base and have 6 significant agreements in place as we conclude 2009 and start 2010.

For a more in-depth review of the company plans for the rest of 2009 and projections for 2010, look for an interview with NavStar's Chairman and CEO N. Douglas Pritt later today at www.tradergains.com.

About NavStar Technologies, Inc.

NavStar (www.navstarinc.com) is focused on the creation of products and services that provide tracking and monitoring of vehicles and high value cargo, equipment, and other valuable and personal assets.

ECOtality Signs Definitive Agreements for $15.5 Million Capital Raise

Transaction eliminates all $9.1 million of existing debt and provides capital to support ECOtality's anticipated growth

SCOTTSDALE, Ariz., Nov 04, 2009 -- ECOtality, Inc. (OTCBB: ETLY), a leader in clean electric transportation and storage technologies, today announced it has entered into definitive agreements with institutional investors, including existing shareholders, for a capital investment of approximately $15.5 million in equity financing. In addition to the capital raise, the debenture holders of ECOtality will convert all $9.1 million of existing debentures and related warrants into equity.

The net proceeds of the investment funds will be utilized as working capital to support the initial requirements of the $99.8 million award from the Department of Energy and will provide the Company with the necessary financial capabilities to meet its anticipated expansion as a leader in electric vehicle (EV) charging infrastructure.

"This investment reflects a strong confidence in the Company by new and current investors and significantly strengthens our financial position as we seek to increase shareholder value through strong bottom line growth," said Jonathan Read, president and CEO, ECOtality. "The financing provides an adequate level of working capital to support the initial requirements of our recent $99.8 million government award, which undertakes the largest deployment of electric vehicles (EVs) and charging infrastructure in history. With this capital we are able to better leverage our unparalleled EV infrastructure experience and superior charging technologies to become the immediate international leader in EV infrastructure." The capital raise coincides with ECOtality's recent award of $99.8 million from the U.S. Department of Energy that was supplemented by an additional commitment of $8 million from the California Energy Commission for the largest deployment of EVs and charging infrastructure ever undertaken in The EV Project (www.theEVproject.com). In partnership with Nissan and over 40 different industry partners, ECOtality's subsidiary eTec is project manager for The EV Project which will deploy 10,950 Level 2 (220V) charging systems, 260 Level 3 fast-chargers and 4,700 Nissan LEAF zero-emission electric vehicles in five states.

Concurrent with the transaction, ECOtality will provide the required notice to the Financial Industry Regulatory Authority (FINRA) to enact a 1:60 reverse stock split that was approved by shareholders at the August 26, 2009 Annual Shareholder Meeting. In addition, the Board authorized Company management to submit an application to be listed on The NASDAQ Stock Market after completing the reverse stock split. There can be no assurance that the company can meet the listing requirements of the NASDAQ Stock market.

The shares offered will not be or have not been registered under the Securities Act of 1933 and may not be offered or sold absent registration or an applicable exemption from registration. The Company may at its option expand this Private Placement.

The Company has agreed to file a registration statement with the Securities and Exchange Commission (SEC) covering the resale of the shares of common stock, including the shares of common stock issuable upon exercise of the warrants, issued in the private placement.

This notice is issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state.

For specific information regarding the transaction please see the associated 8-K filing.

About ECOtality, Inc.

ECOtality, Inc. (OTCBB:ETLY), headquartered in Scottsdale, Arizona, is a leader in clean electric transportation and storage technologies. Through innovation, acquisitions, and strategic partnerships, ECOtality accelerates the market applicability of advanced electric technologies to replace carbon-based fuels. For more information about ECOtality, Inc., please visit www.ecotality.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "anticipates," "expects," "intends," "plans," "'believes," "estimates," "may," "will," and variations of these words are intended to identify forward-looking statements. These statements include, but are not limited to, statements about the expected effects of the financing and the conversion of our outstanding securities, our future performance and prospects, our capital needs, our expansion and operating strategies, the demand for and market acceptance of our products and technologies, and our competitive position. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the Company's actual results to differ materially from those indicated in the forward-looking statements.

Advanced Cell Technology Announces Upcoming Milestones at BIO Europe 2009

IND Filing for RPE Program Expected by 2009 Year-end; Company Announces Plans to File IND For Second Clinical Program During First Half of 2010

WORCESTER, Mass., Nov 03, 2009 -- Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTCBB: ACTC) announced today that its Chief Executive Officer, William Caldwell, IV, presented at the BIO Europe Conference being held in Vienna, Austria. The presentation provided a corporate overview and update on the Company's plans for its clinical pathway in addition to several other upcoming developmental milestones, including its planned IND filing with the FDA for its retinal pigment epithelial (RPE) program prior to the end of this year, and its goal of becoming one of the first companies to treat a patient with an embryonic stem cell based therapy, which it hopes to achieve by the third quarter of 2010. Pending FDA approval, ACT hopes to commence Phase I clinical trials for its first IND designation in the summer of 2010, and anticipates filing an IND for an additional retinal indication in a similar timeframe. "We are extremely pleased to have the opportunity to announce exciting upcoming corporate developments at such a prestigious gathering of Europe's finest biotech organizations," remarked William Caldwell, CEO of ACT. "We expect that this presentation will serve to greatly enhance our visibility within the international biotech community and could lead to further interest from potential strategic partners who would be interested in working with us in further developing our portfolio of potentially revolutionary regenerative therapies." BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts top executives from the biotechnology, pharmaceutical and finance industries, along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a "must attend" event for the biotech industry.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.

Forward-Looking Statements Statements in this news release regarding future ability to draw on the credit Facility, future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the Company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of its intellectual property, and economic conditions generally. Additional information on potential factors that could affect the Company's results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-K for the year ended December 31, 2008. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.

Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx

CONTACT: Jason A. Hilton, Standout Stocks Tel: +1 585 729 8809 e-mail: Jason@Newmediaadvisorsllc.com e-mail: info@standoutstocks.com WWW: http://www.standoutstocks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: acquisition, appointment, arizona, austria, biotechnology, broker, california, cargo, cellular, ceo, china, clinical, coal, coal mining, community, conference, corporate, dealer, debentures, debt, department of energy, ecuador, email, e-mail, energy, equity, europe, exercise, expansion, fda, finance, government, healthcare, indiana, investment, investment opinion, joint venture, korea, legal, manufacturing, market, medical, medicine, online, otc, partnership, pharmaceuticals, president, prices, Private Placement, products, property, research and development, sec, securities, securities law, ship, stock split, subscription, technology, trial, web